SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-000316
Filing Date
2023-01-03
Accepted
2023-01-03 15:45:21
Documents
2
Group Members
MARK ANGELOSC-SIGMA GLOBAL PARTNERS, LPYA GLOBAL INVESTMENTS II (U.S.), LPYA II GP, LPYAII GP II, LLCYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm231355d5_sc13ga.htm SC 13G/A 131026
2 EXHIBIT 99.1 tm231355d5_ex99-1.htm EX-99.1 10547
  Complete submission text file 0001104659-23-000316.txt   143622
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

IRS No.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Subject) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-89881 | Film No.: 23501915
SIC: 2834 Pharmaceutical Preparations